Literature DB >> 18809676

Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors.

Oliver Anderka1, Janina Boyken, Ursula Aschenbach, Andreas Batzer, Oliver Boscheinen, Dieter Schmoll.   

Abstract

Glucokinase (GK) is a key enzyme of glucose metabolism in liver and pancreatic beta-cells, and small molecule activators of GK (GKAs) are under evaluation for the treatment of type 2 diabetes. In liver, GK activity is controlled by the GK regulatory protein (GKRP), which forms an inhibitory complex with the enzyme. Here, we performed isothermal titration calorimetry and surface plasmon resonance experiments to characterize GK-GKRP binding and to study the influence that physiological and pharmacological effectors of GK have on the protein-protein interaction. In the presence of fructose-6-phosphate, GK-GKRP complex formation displayed a strong entropic driving force opposed by a large positive enthalpy; a negative change in heat capacity was observed (Kd = 45 nm, DeltaH = 15.6 kcal/mol, TDeltaS = 25.7 kcal/mol, DeltaCp = -354 cal mol(-1) K(-1)). With k(off) = 1.3 x 10(-2) s(-1), the complex dissociated quickly. The thermodynamic profile suggested a largely hydrophobic interaction. In addition, effects of pH and buffer demonstrated the coupled uptake of one proton and indicated an ionic contribution to binding. Glucose decreased the binding affinity between GK and GKRP. This decrease was potentiated by an ATP analogue. Prototypical GKAs of the amino-heteroaryl-amide type bound to GK in a glucose-dependent manner and impaired the association of GK with GKRP. This mechanism might contribute to the antidiabetic effects of GKAs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809676     DOI: 10.1074/jbc.M805434200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Mutational analysis of allosteric activation and inhibition of glucokinase.

Authors:  Bogumil Zelent; Stella Odili; Carol Buettger; Dorothy K Zelent; Pan Chen; Deborah Fenner; Joseph Bass; Charles Stanley; Monique Laberge; Jane M Vanderkooi; Ramakanth Sarabu; Joseph Grimsby; Franz M Matschinsky
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

2.  Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.

Authors:  Ling Song; Yi Zhang; Ji Jiang; Shuang Ren; Li Chen; Dongyang Liu; Xijing Chen; Pei Hu
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

3.  Turning enzymes ON with small molecules.

Authors:  Julie A Zorn; James A Wells
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

4.  Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis.

Authors:  Ziqi Lin; Yue Wang; Bao Zhang; Zhen Jin
Journal:  Endocrine       Date:  2018-08-08       Impact factor: 3.633

5.  Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.

Authors:  Krishna Saxena; Ulrich Schieborr; Oliver Anderka; Elke Duchardt-Ferner; Bettina Elshorst; Santosh Lakshmi Gande; Julia Janzon; Denis Kudlinzki; Sridhar Sreeramulu; Matthias K Dreyer; K Ulrich Wendt; Corentin Herbert; Philippe Duchaussoy; Marc Bianciotto; Pierre-Alexandre Driguez; Gilbert Lassalle; Pierre Savi; Moosa Mohammadi; Françoise Bono; Harald Schwalbe
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

6.  Structural basis for regulation of human glucokinase by glucokinase regulatory protein.

Authors:  Tobias Beck; Brian G Miller
Journal:  Biochemistry       Date:  2013-08-26       Impact factor: 3.162

Review 7.  Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.

Authors:  Yolanda F Otero; John M Stafford; Owen P McGuinness
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

8.  Antidiabetic Disruptors of the Glucokinase-Glucokinase Regulatory Protein Complex Reorganize a Coulombic Interface.

Authors:  Juliana A Martinez; Qing Xiao; Armen Zakarian; Brian G Miller
Journal:  Biochemistry       Date:  2017-06-07       Impact factor: 3.162

Review 9.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

10.  Small-Molecule Allosteric Activation of Human Glucokinase in the Absence of Glucose.

Authors:  Joseph M Bowler; Katherine L Hervert; Mark L Kearley; Brian G Miller
Journal:  ACS Med Chem Lett       Date:  2013-09-05       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.